Researchers at the University of Alberta, Allison Kraus, stumbled across a discovery that is deemed to be a breakthrough in the treatment of multiple sclerosis.

The surprise finding is believed to have the potential to revolutionize the research into MS as it affects all the myelin diseases.

The 26-year-old Karus is a PhD student, who was studying gene calnexin under the supervision of Marek Michalak.

During the sessions, they observed that when the gene was put out of action in the mice the animals witnessed issues in mobility, thereby leading to difficulty in walking and even paralysis in the back legs. Post an in-depth examination of inside the mice, it was found that after disabling the gene, deformations formulated in the tissues of the nerves of the animal.

The same problems and deformations are also encountered in the patients who are suffering from MS.

Delighted with the surprise finding, Kraus and Dr. Michalak claimed, “We’re very excited about our findings. The beauty of this is that this really arises from curiosity-driven research. It’s something we would not have expected”.